KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Return on Capital Employed (2016 - 2026)

Edwards Lifesciences has reported Return on Capital Employed over the past 16 years, most recently at 10.83% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 115.0% year-over-year to 10.83%; the TTM value through Dec 2025 reached 10.83%, down 115.0%, while the annual FY2025 figure was 10.93%, 327.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 10.83% at Edwards Lifesciences, down from 12.09% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 24.95% in Q2 2021 and troughed at 10.83% in Q4 2025.
  • A 5-year average of 17.42% and a median of 16.37% in 2024 define the central range for Return on Capital Employed.
  • On a YoY basis, Return on Capital Employed climbed as much as 1019bps in 2021 and fell as far as -787bps in 2021.
  • Year by year, Return on Capital Employed stood at 23.16% in 2021, then dropped by -13bps to 20.13% in 2022, then dropped by -17bps to 16.7% in 2023, then fell by -28bps to 11.98% in 2024, then fell by -10bps to 10.83% in 2025.
  • Business Quant data shows Return on Capital Employed for EW at 10.83% in Q4 2025, 12.09% in Q3 2025, and 12.4% in Q2 2025.